|
| Exchange Disseminated Time | Gufic Biosciences Ltd has informed BSE that the Company is all set to make foray into "anticancer products". Research & Development has always been the Company's core strength. Currently, the Company is in advanced stage of development of range of anticancer products, which are in lyophilized form. These products are going to be a major import substitute for Indian patients, thus making the medicine affordable. There are very few players in Indian market catering to this area and the Company wants to bridge the gap between affordability and availability. These products are also meant to be exported to various countries.
Further the Company has informed that it may make this information public through proper channels of communication, at appropriate time. |
|
|